AKBA
Price
$3.65
Change
-$0.09 (-2.41%)
Updated
Jun 27, 12:48 PM (EDT)
Capitalization
982.26M
34 days until earnings call
CLRPF
Price
$1.45
Change
+$0.07 (+5.07%)
Updated
Jun 26 closing price
Capitalization
498.79M
Interact to see
Advertisement

AKBA vs CLRPF

Header iconAKBA vs CLRPF Comparison
Open Charts AKBA vs CLRPFBanner chart's image
Akebia Therapeutics
Price$3.65
Change-$0.09 (-2.41%)
Volume$9.84K
Capitalization982.26M
Clarity Pharmaceuticals
Price$1.45
Change+$0.07 (+5.07%)
Volume$1.7K
Capitalization498.79M
AKBA vs CLRPF Comparison Chart in %
Loading...
AKBA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKBA vs. CLRPF commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKBA is a StrongBuy and CLRPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (CLRPF: $1.45)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRPF’s FA Score shows that 0 FA rating(s) are green while.

  • CLRPF’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKBA’s TA Score shows that 4 TA indicator(s) are bullish.

  • AKBA’s TA Score: 4 bullish, 3 bearish.

Price Growth

CLRPF (@Biotechnology) experienced а -2.03% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.94%. For the same industry, the average monthly price growth was +39.30%, and the average quarterly price growth was +17.54%.

Industries' Descriptions

@Biotechnology (+9.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKBA($982M) has a higher market cap than CLRPF($499M). AKBA YTD gains are higher at: 96.842 vs. CLRPF (-46.396). AKBA has higher annual earnings (EBITDA): 6.59M vs. CLRPF (-66.98M).
AKBACLRPFAKBA / CLRPF
Capitalization982M499M197%
EBITDA6.59M-66.98M-10%
Gain YTD96.842-46.396-209%
P/E RatioN/AN/A-
Revenue185MN/A-
Total Cash113MN/A-
Total Debt54.1MN/A-
FUNDAMENTALS RATINGS
AKBA: Fundamental Ratings
AKBA
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKBA
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AKBA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGAIX42.500.42
+1.00%
American Funds Intl Gr and Inc F3
FCIHX17.300.03
+0.17%
NYLI PineStone International Equity Cl P
LGFEX20.57N/A
N/A
Franklin International Equity FI
CMDYX13.38N/A
N/A
Columbia Mid Cap Index Inst3
BUIOX15.62N/A
N/A
Buffalo Early Stage Growth Instl

AKBA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKBA has been loosely correlated with XERS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if AKBA jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKBA
1D Price
Change %
AKBA100%
+1.63%
XERS - AKBA
41%
Loosely correlated
+0.64%
IPSC - AKBA
39%
Loosely correlated
+0.23%
ATOS - AKBA
39%
Loosely correlated
+1.81%
ABOS - AKBA
39%
Loosely correlated
-1.63%
HOWL - AKBA
39%
Loosely correlated
-4.60%
More

CLRPF and

Correlation & Price change

A.I.dvisor tells us that CLRPF and SBHMY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRPF and SBHMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRPF
1D Price
Change %
CLRPF100%
+5.07%
SBHMY - CLRPF
24%
Poorly correlated
N/A
BOLD - CLRPF
23%
Poorly correlated
N/A
AKBA - CLRPF
21%
Poorly correlated
+1.63%
DOSEF - CLRPF
12%
Poorly correlated
N/A
ACUT - CLRPF
9%
Poorly correlated
N/A
More